Marta Vilalta1, Nicholas P Hughes1, Rie Von Eyben1, Amato J Giaccia1, Edward E Graves2. 1. Department of Radiation Oncology, Molecular Imaging Program at Stanford and Bio-X Program, Stanford University, Stanford, CA, USA. 2. Department of Radiation Oncology, Molecular Imaging Program at Stanford and Bio-X Program, Stanford University, Stanford, CA, USA. egraves@stanford.edu.
Abstract
PURPOSE: Preclinical studies of hypoxia are generally done using ectopic xenograft tumors, which behave differently from human tumors. Our previous findings have shown that subcutaneously implanted lung tumors exhibit more hypoxia than their orthotopic implanted or spontaneous K-ras-induced counterparts. We hypothesize that differences in hypoxia are due to site-specific differences in vascularity and perfusion. PROCEDURES: To compare the presence and functionality of vessels in these tumor models, we studied vascular perfusion in vivo in real time. RESULTS: Orthotopically implanted and spontaneous K-ras-induced lung tumors showed elevated perfusion, demonstrating vasculature functionality. Little contrast agent uptake was observed within the subcutaneously implanted tumors, indicating vascular dysfunction. These findings were corroborated at the microscopic level with Hoechst 33342 and Meca-32 staining. CONCLUSIONS: From these observations, we concluded that differences in hypoxia in experimental models is related to vessel perfusion. Thus, appropriate selection of preclinical lung tumor models is essential for the study of hypoxia, angiogenesis and therapies targeting these phenomena.
PURPOSE: Preclinical studies of hypoxia are generally done using ectopic xenograft tumors, which behave differently from humantumors. Our previous findings have shown that subcutaneously implanted lung tumors exhibit more hypoxia than their orthotopic implanted or spontaneous K-ras-induced counterparts. We hypothesize that differences in hypoxia are due to site-specific differences in vascularity and perfusion. PROCEDURES: To compare the presence and functionality of vessels in these tumor models, we studied vascular perfusion in vivo in real time. RESULTS: Orthotopically implanted and spontaneous K-ras-induced lung tumors showed elevated perfusion, demonstrating vasculature functionality. Little contrast agent uptake was observed within the subcutaneously implanted tumors, indicating vascular dysfunction. These findings were corroborated at the microscopic level with Hoechst 33342 and Meca-32 staining. CONCLUSIONS: From these observations, we concluded that differences in hypoxia in experimental models is related to vessel perfusion. Thus, appropriate selection of preclinical lung tumor models is essential for the study of hypoxia, angiogenesis and therapies targeting these phenomena.
Entities:
Keywords:
Non-invasive imaging in animal models; Preclinical models of cancer; Tumor microenvironment; Vasculature; Xenograft models
Authors: E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson Journal: Genes Dev Date: 2001-12-15 Impact factor: 11.361
Authors: H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald Journal: Am J Pathol Date: 2000-04 Impact factor: 4.307
Authors: Bin Chen; Brian W Pogue; Xiaodong Zhou; Julia A O'Hara; Nicolas Solban; Eugene Demidenko; P Jack Hoopes; Tayyaba Hasan Journal: Clin Cancer Res Date: 2005-01-15 Impact factor: 12.531
Authors: Heling Zhou; Olivier Belzile; Zhang Zhang; Jo Wagner; Chul Ahn; James A Richardson; Debabrata Saha; Rolf A Brekken; Ralph P Mason Journal: Magn Reson Med Date: 2019-01-30 Impact factor: 4.668
Authors: Jordan A Torok; Patrick Oh; Katherine D Castle; Michael Reinsvold; Yan Ma; Lixia Luo; Chang-Lung Lee; David G Kirsch Journal: Cancer Res Date: 2018-10-12 Impact factor: 12.701
Authors: Jillian L Perry; Kevin G Reuter; J Christopher Luft; Chad V Pecot; William Zamboni; Joseph M DeSimone Journal: Nano Lett Date: 2017-04-11 Impact factor: 11.189
Authors: Venus Sosa Iglesias; Stefan J van Hoof; Ana Vaniqui; Lotte Ejr Schyns; Natasja Lieuwes; Ala Yaromina; Linda Spiegelberg; Arjan J Groot; Frank Verhaegen; Jan Theys; Ludwig Dubois; Marc Vooijs Journal: Br J Radiol Date: 2018-11-30 Impact factor: 3.039
Authors: Khue G Nguyen; Maura R Vrabel; Siena M Mantooth; Jared J Hopkins; Ethan S Wagner; Taylor A Gabaldon; David A Zaharoff Journal: Front Immunol Date: 2020-10-15 Impact factor: 7.561
Authors: Poorva Ghosh; Yihang Guo; Adnin Ashrafi; Jingyu Chen; Sanchareeka Dey; Shigen Zhong; Jie Liu; James Campbell; Purna Chaitanya Konduri; Jeni Gerberich; Massoud Garrossian; Ralph P Mason; Li Zhang; Li Liu Journal: Cancer Res Date: 2020-06-16 Impact factor: 12.701